Tag: Sintilimab

Neoadjuvant checkpoint blockade in MSI-H/dMMR CRC

Trial
Phase 1/2, NICHE-2, NEOPRISM-CRC
Conference
ASCO 2024
Type
Peer-reviewed article

18 July 2024 15:36

Sintilimab plus chemotherapy improves OS in treatment-naïve, stage III–IV non-squamous NSCLC

Presented By
Dr Yunpeng Yang, Sun Yat-sen University Cancer Center, China
Trial
Phase 3, ORIENT-11
Conference
ELCC 2022
Type
Peer-reviewed article

25 May 2022 12:39

ELCC 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ELCC 2022

19 April 2022 10:43

Sintilimab plus FOLFIRINOX may provide benefits in metastatic pancreatic cancer

Presented By
Dr Qihan Fu, Zhejiang University School of Medicine, China
Trial
Phase 3, CISPD3
Conference
ASCO GI 2022
Type
Peer-reviewed article

21 March 2022 12:43
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com